These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 33488605)

  • 1. IL-33/Vitamin D Crosstalk in Psoriasis-Associated Osteoporosis.
    De Martinis M; Ginaldi L; Sirufo MM; Bassino EM; De Pietro F; Pioggia G; Gangemi S
    Front Immunol; 2020; 11():604055. PubMed ID: 33488605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Vitamin D on the Expression of IL-33 and Its Receptor ST2 in Skin Cells; Potential Implication for Psoriasis.
    Wierzbicka JM; Piotrowska A; Purzycka-Bohdan D; Olszewska A; Nowak JI; Szczerkowska-Dobosz A; Nedoszytko B; Nowicki RJ; Żmijewski MA
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriatic cutaneous inflammation promotes human monocyte differentiation into active osteoclasts, facilitating bone damage.
    Raimondo A; Lembo S; Di Caprio R; Donnarumma G; Monfrecola G; Balato N; Ayala F; Balato A
    Eur J Immunol; 2017 Jun; 47(6):1062-1074. PubMed ID: 28386999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoimmunology: memorandum for rheumatologists.
    Zhao L; Huang L; Zhang X
    Sci China Life Sci; 2016 Dec; 59(12):1241-1258. PubMed ID: 27650950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues.
    Zupan J; Komadina R; Marc J
    J Biomed Sci; 2012 Mar; 19(1):28. PubMed ID: 22380539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible Roles of IL-33 in the Innate-Adaptive Immune Crosstalk of Psoriasis Pathogenesis.
    Cannavò SP; Bertino L; Di Salvo E; Papaianni V; Ventura-Spagnolo E; Gangemi S
    Mediators Inflamm; 2019; 2019():7158014. PubMed ID: 31736655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network pharmacology approach to elucidate possible action mechanisms of Sinomenii Caulis for treating osteoporosis.
    Liu WJ; Jiang ZM; Chen Y; Xiao PT; Wang ZY; Huang TQ; Liu EH
    J Ethnopharmacol; 2020 Jul; 257():112871. PubMed ID: 32325182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of the Immune System with Skin and Bone Tissue in Psoriatic Arthritis: A Comprehensive Review.
    Sukhov A; Adamopoulos IE; Maverakis E
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):87-99. PubMed ID: 26780035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoimmunology: The
    Dar HY; Azam Z; Anupam R; Mondal RK; Srivastava RK
    Front Biosci (Landmark Ed); 2018 Jan; 23(3):464-492. PubMed ID: 28930556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of IL-17A signalling in psoriasis and associated bone loss.
    Uluçkan Ö; Wagner EF
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):17-20. PubMed ID: 27586798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic and pharmacological assessment of murine IL-23 mediated psoriasiform dermatitis; implications for drug discovery.
    Gauld SB; Gauvin D; Olson L; Leys L; Paulsboe S; Liu Z; Edelmayer RM; Wetter J; Salte K; Wang Y; Huang S; Honore P; McGaraughty S
    J Dermatol Sci; 2018 Oct; 92(1):45-53. PubMed ID: 30149967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.
    Novelli L; Chimenti MS; Chiricozzi A; Perricone R
    Autoimmun Rev; 2014 Jan; 13(1):64-9. PubMed ID: 24021172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The physiopathological role of IL-33: new highlights in bone biology and a proposed role in periodontal disease.
    da Luz FA; Oliveira AP; Borges D; Brígido PC; Silva MJ
    Mediators Inflamm; 2014; 2014():342410. PubMed ID: 24692848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D and the Pathophysiology of Inflammatory Skin Diseases.
    Umar M; Sastry KS; Al Ali F; Al-Khulaifi M; Wang E; Chouchane AI
    Skin Pharmacol Physiol; 2018; 31(2):74-86. PubMed ID: 29306952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice.
    Nakamichi Y; Mizoguchi T; Arai A; Kobayashi Y; Sato M; Penninger JM; Yasuda H; Kato S; DeLuca HF; Suda T; Udagawa N; Takahashi N
    Proc Natl Acad Sci U S A; 2012 Jun; 109(25):10006-11. PubMed ID: 22670054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis, vitamin D and the importance of the cutaneous barrier's integrity: An update.
    Mattozzi C; Paolino G; Richetta AG; Calvieri S
    J Dermatol; 2016 May; 43(5):507-14. PubMed ID: 26971536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-33 induces skin inflammation with mast cell and neutrophil activation.
    Hueber AJ; Alves-Filho JC; Asquith DL; Michels C; Millar NL; Reilly JH; Graham GJ; Liew FY; Miller AM; McInnes IB
    Eur J Immunol; 2011 Aug; 41(8):2229-37. PubMed ID: 21674479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ST2 deletion increases inflammatory bone destruction in experimentally induced periapical lesions in mice.
    Velickovic M; Pejnovic N; Mitrovic S; Radosavljevic G; Jovanovic I; Kanjevac T; Jovicic N; Lukic A
    J Endod; 2015 Mar; 41(3):369-75. PubMed ID: 25595464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-33/IL-31 Axis in Osteoporosis.
    De Martinis M; Sirufo MM; Suppa M; Ginaldi L
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32069819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Autocrine Circuit of IL-33 in Keratinocytes Is Involved in the Progression of Psoriasis.
    Zeng F; Chen H; Chen L; Mao J; Cai S; Xiao Y; Li J; Shi J; Li B; Xu Y; Tan Z; Gong F; Li B; Qian Y; Dong L; Zheng F
    J Invest Dermatol; 2021 Mar; 141(3):596-606.e7. PubMed ID: 32853659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.